The association of early toxicity and outcomes for patients treated with abemaciclib.

Authors

null

Hope S. Rugo

University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Hope S. Rugo , George W. Sledge Jr., Stephen R. D. Johnston , Matthew P. Goetz , Miguel Martin , Masakazu Toi , Tammy D Forrester , Martin Frenzel , Joanne Cox , Susana Barriga , Sara M. Tolaney

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Hormone Receptor-Positive

Clinical Trial Registration Number

NCT02102490, NCT02107703, NCT02246621

Citation

J Clin Oncol 36, 2018 (suppl; abstr 1053)

DOI

10.1200/JCO.2018.36.15_suppl.1053

Abstract #

1053

Poster Bd #

134

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Gastrointestinal Cancers Symposium

A survey study of prevention and treatment patterns by academic and community oncologists for cancer therapy-associated diarrhea.

A survey study of prevention and treatment patterns by academic and community oncologists for cancer therapy-associated diarrhea.

First Author: Omkar Subhash Marathe

First Author: Ayca Gucalp